References
- Global initiative for asthma. Global strategy for asthma management and prevention. National Institutes of Health. 2002, Publication 02–3659
- British Guideline on the Management of Asthma. Thorax 2003; 58: il–94, [CSA]
- Burchard E G, Avila P C, Nazario S. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med 2004; 169: 386–392, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boulet L P, Turcotte H, Turcot O. Airway inflammation in asthma with incomplete reversibility of airflow obstruction. Respir Med 2003; 97: 739–744, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Szefler S J, Martin R J, King T S. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109: 410–418, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Faul J L, Demers E A, Burke C M. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma. Chest 2002; 121: 1414–1420, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vonk J M, Jongepier H, Panhuysen C I. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322–327, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- ten B A, Zwinderman A H, Sterk P J. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744–748, [CSA]
- Holt S, Suder A, Weatherall M. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: Meta-analysis. BMJ 2001; 323: 253–256, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Quanjer P H, Tammeling G J, Cotes J E. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: 5–40, suppl 16[CSA]
- Chhabra S K, Vijayan V K, Gupta R, De S. Expression of bronchodilator response: Comparison of four indices. Respir Med 2002; 96: 611–614, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Quadrelli S A, Roncoroni A J, Montiel G C. Evaluation of bronchodilator response in patients with airway obstruction. Respir Med 1999; 93: 630–636, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weir D C, Sherwood Burge P. Measures of reversibility in response to bronchodilators in chronic airflow obstruction: Relation to airway calibre. Thorax 1991; 46: 43–45, [PUBMED], [INFOTRIEVE], [CSA]
- Brand P L, Quanjer P H, Postma D S. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47: 429–436, [PUBMED], [INFOTRIEVE], [CSA]
- Bellia V, Cibella F, Cuttitta G. Effect of age upon airway obstruction and reversibility in adult patients with asthma. Chest 1998; 114: 1336–1342, [PUBMED], [INFOTRIEVE], [CSA]
- Sippel J M, Holden W E, Tilles S A. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 2000; 106: 645–650, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jones S L, Kittelson J, Cowan J O. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164: 738–743, [PUBMED], [INFOTRIEVE], [CSA]
- Newnham D M, McDevitt D G, Lipworth B J. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med 1994; 97: 29–37, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kerstjens H A, Brand P L, Quanjer P H. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group. Thorax 1993; 48: 722–729, [PUBMED], [INFOTRIEVE], [CSA]
- Rasmussen F, Taylor D R, Flannery E M. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: A longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002; 165: 1480–1488, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Little S A, Sproule M W, Cowan M D. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: Reproducibility and relationship with lung function and severity. Thorax 2002; 573: 247–253, [CSA], [CROSSREF]
- Benayoun L, Druilhe A, Dombret M C. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003; 167: 1360–1368, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cassino C, Berger K I, Goldring R M. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000; 162: 1423–1428, [PUBMED], [INFOTRIEVE], [CSA]
- Rodrigo G, Rodrigo C. Effect of age on bronchodilator response in acute severe asthma treatment. Chest 1997; 112: 19–23, [PUBMED], [INFOTRIEVE], [CSA]
- Kizkin O, Turker G, Hacievliyagil S S. Asthma, age, and early reversibility testing. J Asthma 2003; 40: 317–321, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Duncan P G, Brink C, Douglas J S. Beta-receptors during aging in respiratory tissues. Eur J Pharmacol 1982; 78: 45–52, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Janssens J P, Pache J C, Nicod L P. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999; 13: 197–205, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Little S A, MacLeod K J, Chalmers G W. Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med 2002; 112: 446–452, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]